19.67M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer.

Similar securities

Based on sector and market capitalization

Report issue